Duke Cancer Institute forms partnerships to speed drug development

A partnership formed by the Duke Cancer Institute, UNC Lineberger Comprehensive Cancer Center and the Siteman Cancer Center at Washington University in St. Louis will become part of a national network working to accelerate the pace of cancer drug development.

Duke Researchers Discover Breast Cancer Link

Scientists at the Duke Cancer Institute may have found an explanation for the link between obesity and breast cancer: a byproduct of cholesterol that fuels tumors in some of the most common forms of the disease.

Director Named at Duke Cancer Institute

James Abbruzzese, M.D., a leading expert in the clinical study and treatment of pancreatic cancer, has been named chief of the Division of Medical Oncology and associate director for clinical research at the Duke Cancer Institute.

Duke Cancer Institute Honors Researchers with Shingleton Award

The Duke Cancer Institute has named Thomas and Janet Kean of Norwood, N.C., and Nick Valvano of Cary, N.C., president emeritus of The V Foundation for Cancer Research, as the 2013 recipients of the Shingleton Award, which recognizes the outstanding service and generosity of individuals who are committed to the war against cancer.